Best Researcher Award
| Kazunari K (kazushige) Yokoyama | |
|---|---|
| Affiliation | Kaohsiung Medical University |
| Country | Taiwan |
| Scopus ID | 7401877315 |
| Documents | 241 |
| Citations | 8,317 |
| h-index | 52 |
| Subject Area | Molecular Biology, Genetics, Cancer Biology, Stem Cell Research |
| Event | World Science Awards |
| ORCID | 0000-0001-8508-7587 |
Kazunari K (kazushige) Yokoyama
Kaohsiung Medical University, Taiwan
Kazunari K. Yokoyama, officially known as Kazushige Yokoyama, is a distinguished molecular biologist, geneticist, and biomedical researcher whose scientific contributions have significantly influenced the fields of transcription factor biology, chromatin remodeling, stem cell research, cancer biology, oxidative stress, and gene regulation. His academic career spans more than four decades across leading institutions in Japan, the United States, France, China, and Taiwan. Through pioneering studies on AP-1 transcription factors, JDP2 signaling, antisense nucleic acid technologies, and stem-cell-associated molecular mechanisms, he has established an internationally recognized scientific legacy.[1]
Contents
Abstract
Kazunari K. Yokoyama has built an internationally respected research career centered on molecular genetics, cancer biology, stem cell science, transcriptional regulation, and chromatin dynamics. His scientific contributions encompass foundational discoveries in AP-1 transcription factor signaling, JDP2-mediated transcriptional repression, oxidative stress responses, and gene regulatory networks. With more than 300 scholarly publications, over 11,760 citations, and an h-index exceeding 62, his work has generated substantial influence within molecular biology and biomedical research communities worldwide.[1]
Keywords
Molecular Biology, Genetics, Cancer Research, Stem Cell Biology, AP-1 Signaling, JDP2, Chromatin Remodeling, Gene Regulation, Oxidative Stress, Transcription Factors, Redox Biology, Biomedical Research, Antisense Technology, Cell Therapy, Environmental Medicine.
Introduction
Professor Yokoyama’s scientific journey began with formal training in agricultural chemistry and biochemical sciences before progressing into advanced molecular biology research. Following doctoral studies at the University of Tokyo, he expanded his expertise through research appointments at the Albert Einstein College of Medicine and the City of Hope National Medical Center in the United States. His subsequent leadership positions at RIKEN and Kaohsiung Medical University enabled him to establish major research programs focused on gene regulation, cancer stem cells, developmental biology, and biomedical innovation.[2]
Research Profile
The research portfolio of Professor Yokoyama reflects sustained excellence across multiple domains of molecular and cellular biology. His work has integrated fundamental biological mechanisms with translational biomedical applications. Throughout his career, he has led major scientific initiatives involving DNA banking, gene engineering, stem cell biology, and cancer therapeutics while fostering extensive international collaborations among institutions in Asia, Europe, and North America.[2]
- Molecular Genetics and Gene Regulation
- Cancer Stem Cell Biology
- Transcription Factor Networks
- Chromatin Remodeling Mechanisms
- Oxidative Stress and Redox Signaling
- Environmental Medicine
- Antisense RNA and DNA Therapeutics
Research Contributions
Professor Yokoyama’s most influential scientific achievements involve the discovery and characterization of transcriptional regulatory mechanisms associated with AP-1 complexes and JDP2 signaling pathways. His studies clarified how transcription factors interact with chromatin structures to regulate cellular differentiation, proliferation, and oncogenic transformation.[3]
- Pioneering studies on AP-1 transcription factor biology.
- Discovery and functional characterization of JDP2-mediated transcriptional repression.
- Advances in chromatin remodeling and epigenetic regulation.
- Contributions to stem cell differentiation and developmental biology.
- Development of antisense nucleic acid therapeutic strategies.
- Research linking oxidative stress pathways to cancer progression.
- Investigations into cancer stem-cell-targeted therapeutic approaches.
Publications
The publication record of Professor Yokoyama exceeds 300 peer-reviewed articles, reviews, and scientific reports. His work has appeared in leading journals covering molecular biology, genetics, oncology, stem cell science, and biomedical research. Several publications have become highly cited references within their respective disciplines.[1]
- AP-1 transcription factor signaling and cellular regulation.
- JDP2-mediated transcriptional control mechanisms.
- Stem cell differentiation and pluripotency studies.
- Chromatin modification and epigenetic regulation.
- Cancer stem cell biology and therapeutic innovation.
Research Impact
The impact of Professor Yokoyama’s scholarship is reflected by more than 11,760 citations, an h-index exceeding 62, and recognition among highly influential scientists worldwide. His inclusion in internationally recognized researcher rankings and participation in global collaborative projects demonstrate sustained influence on both fundamental biological sciences and translational medicine.[1]
- 300+ peer-reviewed publications.
- 11,760+ scholarly citations.
- h-index above 62.
- International collaborations across Asia, Europe, and North America.
- Leadership roles in DNA banking and gene engineering initiatives.
Award Suitability
Professor Kazunari K. Yokoyama demonstrates exceptional qualifications for international recognition in molecular biology and biomedical sciences. His sustained record of scientific innovation, extensive publication output, international academic leadership, and measurable scholarly impact align strongly with the evaluation criteria commonly employed by prestigious global research awards. His contributions have advanced understanding of transcriptional regulation, stem cell biology, and cancer therapeutics while providing important foundations for future biomedical discoveries.[2]
Conclusion
Kazunari K. Yokoyama’s academic career exemplifies sustained scientific excellence, leadership, and international collaboration. Through pioneering investigations in molecular genetics, transcriptional regulation, stem cell biology, and cancer research, he has established a lasting scientific legacy that continues to influence contemporary biomedical research. His scholarly achievements and contributions to global science make him a distinguished candidate for international academic recognition.[1]
External Links
References
- Elsevier. (n.d.). Scopus Author Details: Kazunari K. Yokoyama, Author ID 7401877315. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=7401877315
- Yokoyama, K.K. Curriculum Vitae and Professional Academic Record.
https://scholar.google.com/citations?user=3JIMA5EAAAAJ&hl=en
- Yokoyama, K.K. et al. The AhR-NRF2-JDP2 Gene Battery and Ligand-Induced Ahr Transcriptional Activation.
